FindTrial
Sign In

Lactate Clearance And Neonatal Sepsis Score

Lactate Clearance And Modified Sepsis Neonatal Score As Markers Of Adverse Outcomes In Neonates With Sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027195
Enrollment
68
Registered
2020-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A499- Bacterial infection, unspecified Health Condition 2: R652- Severe sepsis

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

SHUBHIKA GARG
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neonates with a clinical diagnosis of sepsis, who are blood culture positive or Neonates with clinical diagnosis of sepsis with 2 or more of the following positive lab criteria [TLC 0.2, CRP-positive]

Exclusion criteria

Exclusion criteria: Neonates with Congenital abnormalities, Those who received blood transfusion or infusion Ringerâ??s lactate prior to examination, Neonates on 2nd line antibiotics, Asphyxiated neonates

Design outcomes

Primary

MeasureTime frame
MortalityTimepoint: Recruitment 6 hours 28 days or earlier—

Secondary

MeasureTime frame
To study complications of neonatal sepsis that might develop in infants with lactate clearance 10% and Modified Sepsis Neonatal Scoreâ?¤10 who survive till 28days or earlier.Timepoint: Recruitment, 6hours, 28days or earlier—

Countries

India

Contacts

Public ContactSHUBHIKA GARG

ERAS LUCKNOW MEDICAL COLLEGE AND HOSPITAL

drmmafaridi@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026